Features of patients who developed hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C Virus

BACKGROUND: The features of hepatitis C virus patients with a sustained virologic response (SVR) who developed hepatocellular carcinoma (HCC) after direct-acting antiviral (DAA) therapy are unclear. METHODS: The study population included 1494 DAA-SVR patients without a history of HCC. The cumulative...

Descripción completa

Detalles Bibliográficos
Autores principales: Mawatari, Seiichi, Kumagai, Kotaro, Oda, Kohei, Tabu, Kazuaki, Ijuin, Sho, Fujisaki, Kunio, Tashima, Shuzo, Inada, Yukiko, Uto, Hirofumi, Saisyoji, Akiko, Hiramine, Yasunari, Hashiguchi, Masafumi, Tamai, Tsutomu, Hori, Takeshi, Taniyama, Ohki, Toyodome, Ai, Sakae, Haruka, Kure, Takeshi, Sakurai, Kazuhiro, Moriuchi, Akihiro, Kanmura, Shuji, Ido, Akio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754290/
https://www.ncbi.nlm.nih.gov/pubmed/35020772
http://dx.doi.org/10.1371/journal.pone.0262267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754290/
https://www.ncbi.nlm.nih.gov/pubmed/35020772
http://dx.doi.org/10.1371/journal.pone.0262267

Ejemplares similares